SOLVING PRODUCTION BOTTLENECKS WITH A CUSTOMIZED ADDITIVE FORMULATION © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more about WithStand Antimicrobials, contact Avient at +1.844.4AVIENT (1.844.428.4368) THE CHALLENGE A well-known manufacturer of private label toothbrushes and dental care products for national drug store chains was experiencing several production problems in its molding operations. THE IMPACT Avient was able to reduce lead time on these newly developed additives by a week versus the original supplier, enabling this customer to better manage and control inventory levels. WithStand Antimicrobial Additives provide a proven, effective, durable, uncompromised solution to limit microbe development in finished plastic devices.

But using existing energy infrastructure to deliver these sources, especially among nations that have relied on traditional energy sources for centuries, has limitations. To help address these challenges, Avient teamed up with a leading technology development company. THE SOLUTION Avient worked with the company to develop a novel reinforcement material comprised of Avient Fiber-Line™ carbon fiber tows in which the filaments were manipulated to increase strength and improve abrasion resistance.

You may recognize the two healthcare megatrends that are driving global demand for pharmaceutical packaging, medical devices and drug delivery devices: economic gains in developing nations and an aging global population that requires treatment for chronic conditions. The necessary increase in efficiencies has pushed optimization efforts into every facet of product development and distribution—from supply chain through production. You have an opportunity to drive growth by addressing global demand for your products, which is spiking in direct response to the needs of elderly patients and the increasing number of middle-class consumers in China, India and Brazil, among other nations.

Loss on sale of business, net of tax Business acquisitions, net of cash acquired Proceeds from sale of business and other assets

The Company acquired the Clariant Masterbatch business ("CMB") on Business Segment Operations (Unaudited) The following pro forma adjustments are referenced by management to provide comparable business performance by incorporating the Clariant Masterbatch business in periods prior to the acquisition date (

business (including the Dyneema® brand) ("Dyneema") and that it is exploring the sale of its Distribution business. to discuss second quarter results and provide more details about the Dyneema acquisition and potential sale of its Distribution business. Business Segment Operations (Unaudited)

Completed acquisition of Clariant's masterbatch business for net purchase price of approximately $1.4 billion and announced new company name: Avient Corporation Business acquisitions, net of cash acquired Avient Corporation Business Segment Operations (Unaudited) (In millions)

As a sitting executive and leader at a multi-national corporation, Mr. Patterson is particularly well qualifieff d to serve on our Board and as our Chairman, as his past and future service enables him to develop comprehensive knowledge of the various segments of our industry and business and of the critical internal and external challenges we face. Powell Retired Chairman andChief Executive Officff er of National Starch and Chemical Company, a specialty chemicals company.

Research and Development We have substantial technology and development capabilities. We operate research and development centers that support our commercial development activities and manufacturing operations. POWELL Retired Chairman and Chief Executive Officer, National Starch and Chemical Company Committee: 2* KERRY J.

Doing so not only strengthens their business and builds goodwill with Avient, but also multiplies the positive impact on our planet. Our Businesses